| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.4 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |